Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977048848> ?p ?o ?g. }
- W1977048848 endingPage "522" @default.
- W1977048848 startingPage "515" @default.
- W1977048848 abstract "Fatty acid amide hydrolase (FAAH) catalyzes the hydrolysis of bioactive fatty acid amides and esters such as the endogenous cannabinoid receptor ligands, anandamide (N-arachidonoyl-ethanolamine) and 2-arachidonoylglycerol, and the putative sleep inducing factor cis-9-octadecenoamide (oleamide). Most FAAH blockers developed to date also inhibit cytosolic phospholipase A2 (cPLA2) and/or bind to the CB1 cannabinoid receptor subtype. Here we report the finding of four novel FAAH inhibitors, two of which, malhamensilipin A and grenadadiene, were screened out of a series of thirty-two different algal natural products, and two others, arachidonoylethylene glycol (AEG) and arachidonoyl-serotonin (AA-5-HT) were selected out of five artificially functionalized polyunsaturated fatty acids. When using FAAH preparations from mouse neuroblastoma N18TG2 cells and [14C]anandamide as a substrate, the IC50s for these compounds ranged from 12.0 to 26 microM, the most active compound being AA-5-HT. This substance was also active on FAAH from rat basophilic leukaemia (RBL-2H3) cells (IC50 = 5.6 microM), and inhibited [14C]anandamide hydrolysis by both N18TG2 and RBL-2H3 intact cells without affecting [14C]anandamide uptake. While AEG behaved as a competitive inhibitor and was hydrolyzed to arachidonic acid (AA) by FAAH preparations, AA-5-HT was resistant to FAAH-catalyzed hydrolysis and behaved as a tight-binding, albeit non-covalent, mixed inhibitor. AA-5-HT did not interfere with cPLA2-mediated, ionomycin or antigen-induced release of [3H]AA from RBL-2H3 cells, nor with cPLA2 activity in cell-free experiments. Finally, AA-5-HT did not activate CB1 cannabinoid receptors since it acted as a very weak ligand in in vitro binding assays, and, at 10-15 mg/kg body weight, it was not active in the 'open field', 'hot plate' and rectal hypothermia tests carried out in mice. Conversely AEG behaved as a cannabimimetic substance in these tests as well as in the 'ring' immobility test where AA-5-HT was also active. AA-5-HT is the first FAAH inhibitor reported to date which is inactive both against cPLA2 and at CB1 receptors, whereas AEG represents a new type of cannabinoid receptor agonist." @default.
- W1977048848 created "2016-06-24" @default.
- W1977048848 creator A5013138756 @default.
- W1977048848 creator A5021209664 @default.
- W1977048848 creator A5029158702 @default.
- W1977048848 creator A5033896936 @default.
- W1977048848 creator A5062572691 @default.
- W1977048848 creator A5076395210 @default.
- W1977048848 creator A5078651116 @default.
- W1977048848 creator A5082040442 @default.
- W1977048848 creator A5085958894 @default.
- W1977048848 date "1998-07-01" @default.
- W1977048848 modified "2023-09-27" @default.
- W1977048848 title "Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase" @default.
- W1977048848 cites W1513097147 @default.
- W1977048848 cites W1636945110 @default.
- W1977048848 cites W1664326306 @default.
- W1977048848 cites W172430044 @default.
- W1977048848 cites W1882501940 @default.
- W1977048848 cites W1969338731 @default.
- W1977048848 cites W1974385498 @default.
- W1977048848 cites W1978147839 @default.
- W1977048848 cites W1978379381 @default.
- W1977048848 cites W1989073099 @default.
- W1977048848 cites W1995158268 @default.
- W1977048848 cites W1999822120 @default.
- W1977048848 cites W2006280591 @default.
- W1977048848 cites W2009051797 @default.
- W1977048848 cites W2020678194 @default.
- W1977048848 cites W2024653583 @default.
- W1977048848 cites W2028420970 @default.
- W1977048848 cites W2041074139 @default.
- W1977048848 cites W2042544913 @default.
- W1977048848 cites W2046945092 @default.
- W1977048848 cites W2056416370 @default.
- W1977048848 cites W2060190913 @default.
- W1977048848 cites W2082779257 @default.
- W1977048848 cites W2082878699 @default.
- W1977048848 cites W2085741941 @default.
- W1977048848 cites W2085842962 @default.
- W1977048848 cites W2087576138 @default.
- W1977048848 cites W2099980267 @default.
- W1977048848 cites W2113920734 @default.
- W1977048848 cites W2126207307 @default.
- W1977048848 cites W2132470832 @default.
- W1977048848 cites W2137704643 @default.
- W1977048848 cites W2152872852 @default.
- W1977048848 cites W86040268 @default.
- W1977048848 doi "https://doi.org/10.1006/bbrc.1998.8874" @default.
- W1977048848 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9703957" @default.
- W1977048848 hasPublicationYear "1998" @default.
- W1977048848 type Work @default.
- W1977048848 sameAs 1977048848 @default.
- W1977048848 citedByCount "167" @default.
- W1977048848 countsByYear W19770488482012 @default.
- W1977048848 countsByYear W19770488482013 @default.
- W1977048848 countsByYear W19770488482014 @default.
- W1977048848 countsByYear W19770488482015 @default.
- W1977048848 countsByYear W19770488482016 @default.
- W1977048848 countsByYear W19770488482017 @default.
- W1977048848 countsByYear W19770488482018 @default.
- W1977048848 countsByYear W19770488482019 @default.
- W1977048848 countsByYear W19770488482020 @default.
- W1977048848 countsByYear W19770488482021 @default.
- W1977048848 countsByYear W19770488482022 @default.
- W1977048848 crossrefType "journal-article" @default.
- W1977048848 hasAuthorship W1977048848A5013138756 @default.
- W1977048848 hasAuthorship W1977048848A5021209664 @default.
- W1977048848 hasAuthorship W1977048848A5029158702 @default.
- W1977048848 hasAuthorship W1977048848A5033896936 @default.
- W1977048848 hasAuthorship W1977048848A5062572691 @default.
- W1977048848 hasAuthorship W1977048848A5076395210 @default.
- W1977048848 hasAuthorship W1977048848A5078651116 @default.
- W1977048848 hasAuthorship W1977048848A5082040442 @default.
- W1977048848 hasAuthorship W1977048848A5085958894 @default.
- W1977048848 hasConcept C148001335 @default.
- W1977048848 hasConcept C158026453 @default.
- W1977048848 hasConcept C170493617 @default.
- W1977048848 hasConcept C181199279 @default.
- W1977048848 hasConcept C185592680 @default.
- W1977048848 hasConcept C2776551241 @default.
- W1977048848 hasConcept C2778078955 @default.
- W1977048848 hasConcept C2778938600 @default.
- W1977048848 hasConcept C2779783865 @default.
- W1977048848 hasConcept C2780871563 @default.
- W1977048848 hasConcept C2781144285 @default.
- W1977048848 hasConcept C46721173 @default.
- W1977048848 hasConcept C55493867 @default.
- W1977048848 hasConceptScore W1977048848C148001335 @default.
- W1977048848 hasConceptScore W1977048848C158026453 @default.
- W1977048848 hasConceptScore W1977048848C170493617 @default.
- W1977048848 hasConceptScore W1977048848C181199279 @default.
- W1977048848 hasConceptScore W1977048848C185592680 @default.
- W1977048848 hasConceptScore W1977048848C2776551241 @default.
- W1977048848 hasConceptScore W1977048848C2778078955 @default.
- W1977048848 hasConceptScore W1977048848C2778938600 @default.
- W1977048848 hasConceptScore W1977048848C2779783865 @default.
- W1977048848 hasConceptScore W1977048848C2780871563 @default.